Cancer Care Ontario | Cancer Care Ontario

21 Results

Guidelines and Advice

Consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiotherapy treatment in Ontario

Status: Current
ID: GL 21-6

Apr 2023

Guidelines and Advice

Contouring Nomenclature - Recommendation Report (Head and Neck Cancer)

Status: Current
ID: GL-C50-12

Feb 2014

Guidelines and Advice

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Status: In-Review
ID: GL-END 3-21

Jan 2018

Guidelines and Advice

Combined Modality Radiotherapy and Chemotherapy in the Non-surgical Management of Localized Carcinoma of the Esophagus

Status: Education and Information
ID: 2-12
Version: 2

Oct 2013

Guidelines and Advice

Chemotherapy or Radiotherapy for Resectable Pancreatic Adenocarcinoma

Status: Archived
ID: 2-23
Version: 2-23 Version 2

Oct 2015

Guidelines and Advice

Computerized Prescriber Order Entry (CPOE) in the Outpatient Oncology Setting

Status: Current
ID: 12-14

May 2012

Guidelines and Advice

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Status: Current
ID: GL 4-18
Version: N/A

Sep 2020

Guidelines and Advice

Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum

Status: Current
ID: GL 3-20
Version: N/A

Aug 2019

Guidelines and Advice

Continuous versus Intermittent Chemotherapy Strategies in Inoperable, Advanced Colorectal Cancer

Status: Current
ID: 2-6
Version: 2

Sep 2022

Guidelines and Advice

Chemotherapy (i.e., Gemcitabine, Docetaxel Plus Gemcitabine, Doxorubicin, or Trabectedin) for Inoperable, Locally Advanced, Recurrent, or Metastatic Uterine Leiomyosarcoma

Status: Archived
ID: GL 11-11

Jul 2012

Guidelines and Advice

Capecitabine in Stage IV Breast Cancer

Status: Archived
ID: 1-16
Version: 2

Sep 2011

Guidelines and Advice

Cancer-Related Pain Management: a Report of Evidence-based Recommendations to Guide Practice

Status: Archived
ID: 16-2

Mar 2008

Consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiotherapy treatment in Ontario

Contouring Nomenclature - Recommendation Report (Head and Neck Cancer)

Cancer Care Ontario Bladder Cancer Guideline: An Endorsement of the 2017 American Urological Association Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA, ASCO, ASTRO, SUO Guide

Combined Modality Radiotherapy and Chemotherapy in the Non-surgical Management of Localized Carcinoma of the Esophagus

Chemotherapy or Radiotherapy for Resectable Pancreatic Adenocarcinoma

Computerized Prescriber Order Entry (CPOE) in the Outpatient Oncology Setting

Consolidation or maintenance systemic therapy for newly diagnosed stage II, III, or IV epithelial ovary, fallopian tube, or primary peritoneal carcinoma

Complex surgery and perioperative systemic therapy for genitourinary cancer of the retroperitoneum

Continuous versus Intermittent Chemotherapy Strategies in Inoperable, Advanced Colorectal Cancer

Chemotherapy (i.e., Gemcitabine, Docetaxel Plus Gemcitabine, Doxorubicin, or Trabectedin) for Inoperable, Locally Advanced, Recurrent, or Metastatic Uterine Leiomyosarcoma

Capecitabine in Stage IV Breast Cancer

Cancer-Related Pain Management: a Report of Evidence-based Recommendations to Guide Practice

Pages